Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,080Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Polfa Tarchomin

02 3Accord healthcare

03 6Actavis Inc

04 5Alembic Pharmaceuticals Limited

05 4Alphapharm PTY Ltd

06 2Apotex Inc

07 3Aurobindo Pharma Limited

08 3Avery Pharmaceuticals

09 5Barr Laboratories

10 3Biodeal Pharmaceuticals

11 4CPS Cito Pharma Services GmbH

12 3Chartwell Pharmaceuticals llc

13 7Cheplapharm Arzneimittel Gmbh

14 5ENDO OPERATIONS

15 16F. Hoffmann-La Roche

16 1Halewood Laboratories Pvt. Ltd

17 4Indo Pharma

18 3Intas Pharmaceuticals

19 2LABORATOIRE RIVA INC.

20 2MS Pharma

21 3NORVIUM BIOSCIENCE

22 4Neuraxpharm

23 4ORIFARM GROUP AS

24 3PRO DOC LIMITEE

25 7Pharmaco

26 4Pharmaco Distribution

27 10Pharmascience Inc.

28 3Prinston

29 3R Key Enterprises

30 12RELIANCE FORMULATION PVT. LTD

31 4Ram Pharma

32 3Rubicon Research

33 3Sandoz B2B

34 8Sun Pharmaceutical Industries Limited

35 6Teva Pharmaceutical Industries

36 1Vaishali Pharma Ltd

37 3Verve Human Care Laboratories

38 1XL Laboratories Private Limited

39 7Zim Laboratories

40 5Zota Healthcare Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Regulatory Info : Dossier Available

Registration Country : Poland

Clonazepam

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Dossier Available

Registration Country : Poland

Polfa Tarchomin

02

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Regulatory Info : Dossier Available

Registration Country : Poland

Clonazepam

Brand Name :

Dosage Form : Tablet

Dosage Strength : 2MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Dossier Available

Registration Country : Poland

Polfa Tarchomin

03

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Regulatory Info : Dossier Available

Registration Country : Poland

Clonazepam

Brand Name :

Dosage Form : Solution for Injection

Dosage Strength : 1MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Dossier Available

Registration Country : Poland

Polfa Tarchomin

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : CLONAZEPAM

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 1996-10-31

Application Number : 74869

Regulatory Info : RX

Registration Country : USA

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : CLONAZEPAM

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 1996-10-31

Application Number : 74869

Regulatory Info : RX

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : CLONAZEPAM

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 1996-10-31

Application Number : 74869

Regulatory Info : RX

Registration Country : USA

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 1982-01-01

Application Number : 17533

Regulatory Info : RX

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 1982-01-01

Application Number : 17533

Regulatory Info : RX

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 1982-01-01

Application Number : 17533

Regulatory Info : RX

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN

Dosage Form : TABLET;ORAL

Dosage Strength : 0.125MG

Packaging :

Approval Date : 1997-04-09

Application Number : 17533

Regulatory Info : DISCN

Registration Country : USA

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date : 1997-04-09

Application Number : 17533

Regulatory Info : DISCN

Registration Country : USA

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN RAPIDLY DISINTEGRATING

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : 0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1997-12-23

Application Number : 20813

Regulatory Info : DISCN

Registration Country : USA

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN RAPIDLY DISINTEGRATING

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1997-12-23

Application Number : 20813

Regulatory Info : DISCN

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN RAPIDLY DISINTEGRATING

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1997-12-23

Application Number : 20813

Regulatory Info : DISCN

Registration Country : USA

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN RAPIDLY DISINTEGRATING

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1997-12-23

Application Number : 20813

Regulatory Info : DISCN

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : KLONOPIN RAPIDLY DISINTEGRATING

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1997-12-23

Application Number : 20813

Regulatory Info : DISCN

Registration Country : USA

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : CLONAZEPAM

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 1996-09-10

Application Number : 74569

Regulatory Info : RX

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : CLONAZEPAM

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 1996-09-10

Application Number : 74569

Regulatory Info : RX

Registration Country : USA

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : CLONAZEPAM

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 1996-09-10

Application Number : 74569

Regulatory Info : RX

Registration Country : USA

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CLONAZEPAM

Brand Name : CLONAZEPAM

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 1998-08-04

Application Number : 74920

Regulatory Info : DISCN

Registration Country : USA

blank